Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MASHNET, also known as The MASH Network, is a specialized clinical research organization (CRO) and site management organization (SMO) focused on liver diseases, particularly Metabolic Dysfunction-Associated Steatohepatitis (MASH). The organization provides a centralized platform for pharmaceutical companies to conduct clinical trials by connecting them with a network of high-performing clinical sites. MASHNET offers services such as patient recruitment, standardized diagnostic imaging, and trial management to accelerate the development of therapies for MASH and related metabolic disorders. By leveraging a network of expert hepatologists and specialized infrastructure, the company aims to overcome the common challenges of patient identification and retention in liver disease research. The organization also maintains a comprehensive patient registry to facilitate rapid enrollment and longitudinal data analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MASHNET.